Gunot, Adelaida G.

HRN: 27-50-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2025
CEFTRIAXONE 1G (VIAL)
08/06/2025
08/13/2025
IV
2g
1hr PTOR Then Q24h
1. Fracture, Closed, Complete, Distal 3rd Radius Ulna Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: